scanX
Metropolis Healthcare
add_icon

Metropolis Healthcare

555.35
+19.20
(3.58%)
Market Cap
11,513.95 Cr
PE Ratio
58.30
Volume
4,60,621.00
Day High - Low
565.00 - 531.00
52W High-Low
600.00 - 411.25
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
11,513.95 Cr
EPS
9.19
PE Ratio
58.30
PB Ratio
7.36
Book Value
72.98
EBITDA
391.86
Dividend Yield
0.00 %
Industry
Healthcare Services
Sector
Healthcare Service Provider
Return on Equity
10.90
Debt to Equity
0.17
Analyst Rating and Forecast
- By Refinitiv from18 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+77.78 %
+77.78 %
Hold
Hold+11.11 %
+11.11 %
Sell
Sell+11.11 %
+11.11 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Metropolis Healthcare schedules investor meetings2 days ago
Metropolis Healthcare will hold analyst meetings on June 3 and June 11, 2026, with Morgan Stanley India and Choice Broking.
neutral
Metropolis Healthcare Q4FY26 Earnings Call Audio AvailableMay 15, 2026
Metropolis Healthcare confirms audio recording of Q4FY26 earnings conference call held on May 14, 2026 at 9:00 am IST is now available on the company's website.
positive
Metropolis Healthcare Sets 13-15% Growth Target for FY27May 14, 2026
Metropolis Healthcare targets 13-15% growth for FY27. Q4FY26 revenue rose 23% YoY to INR 425 Cr, EBITDA surged 71% to INR 108 Cr, PAT up 75% to INR 51 Cr.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Dr. Lal Path Labs
1,607.40
#1 26,932.79
53.21
#1 2,762.90
8.15
#1 510
-14.98
55.66
Vijaya Diagnostic Centre
1,308.50
13,464.04
75.02
814.20
16.36
182
37.25
66.06
Metropolis Healthcare
555.35
#3 11,513.95
#8 58.30
#2 1,645.85
#4 22.25
#2 185
#5 74.66
65.88
Thyrocare Technologies
506.30
8,058.54
50.08
829.04
18.06
156
125.46
70.10
Nephrocare Health Services
598.70
6,007.40
79.11
998.85
29.74
62
22.09
53.96
Krsnaa Diagnostics
549.45
1,782.34
17.24
772.77
4.05
106
101.45
36.67
Suraksha Diagnostic
285.80
1,488.47
47.73
310.41
21.30
34
-13.89
45.91
3B BlackBio DX
1,241.20
1,065.28
18.08
111.60
28.72
48
65.93
46.82
Health X Platform
307.25
977.38
33.46
1,170.80
-18.47
-134
101.06
59.61
One Global Service Provider
445.35
870.33
#1 13.31
147.80
#1 134.60
19
#1 520.00
43.67
Growth Rate
Revenue Growth
22.25 %
Net Income Growth
27.48 %
Cash Flow Change
-0.50 %
ROE
-6.76 %
ROCE
-11.55 %
EBITDA Margin (Avg.)
-0.80 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
178
198
193
203
205
225
225
210
146
291
279
294
346
308
296
312
283
305
292
284
280
310
293
334
316
353
325
352
394
430
415
433
Expenses
132
146
142
145
156
161
159
173
131
198
188
195
224
212
218
231
211
221
215
212
214
234
226
251
235
260
251
283
296
321
320
317
EBITDA
46
53
51
58
49
64
66
37
15
94
90
99
122
96
78
81
72
83
77
72
66
76
67
83
81
93
75
69
97
109
95
116
Operating Profit %
25 %
25 %
26 %
28 %
24 %
28 %
29 %
16 %
8 %
32 %
32 %
33 %
31 %
30 %
26 %
24 %
24 %
26 %
25 %
25 %
23 %
24 %
22 %
24 %
25 %
26 %
22 %
18 %
23 %
25 %
21 %
25 %
Depreciation
5
5
5
5
8
9
11
11
10
11
11
14
13
15
17
18
21
22
23
23
21
22
25
26
26
27
28
29
31
32
32
39
Interest
0
0
0
0
2
2
2
2
2
2
2
3
6
3
5
6
8
7
6
6
6
6
5
6
5
5
5
5
5
6
6
8
Profit Before Tax
42
48
46
52
39
53
53
23
4
81
78
82
103
78
56
57
43
55
48
42
39
48
37
51
51
61
42
36
61
71
57
70
Tax
14
18
14
17
12
10
11
8
1
21
19
20
28
19
15
16
9
14
12
8
10
13
10
14
13
15
11
7
16
18
15
19
Net Profit
27
30
31
35
27
43
42
16
3
61
59
61
75
58
41
40
34
41
36
34
29
36
27
37
38
47
32
29
45
53
42
51
EPS in ₹
4.83
6.14
6.26
6.87
5.34
8.57
8.38
3.09
0.57
11.88
11.50
12.05
14.65
11.39
8.02
7.81
6.53
7.88
6.99
6.51
5.62
6.92
5.30
7.11
7.41
9.08
6.12
5.69
8.70
10.17
7.99
2.46
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
530
553
752
1,004
1,530
1,502
1,555
1,867
2,138
Fixed Assets
207
213
296
343
1,059
1,121
1,177
1,447
941
Current Assets
300
305
397
609
393
303
316
346
469
Capital Work in Progress
0
6
3
0
6
20
0
0
0
Investments
102
33
14
10
16
15
55
71
46
Other Assets
221
301
439
651
450
347
323
349
0
Total Equity & Liabilities
530
553
752
1,004
1,530
1,502
1,555
1,867
2,138
Current Liabilities
91
125
170
204
302
265
246
294
334
Non Current Liabilities
11
8
58
92
341
246
210
238
280
Total Equity
429
420
525
708
888
991
1,099
1,335
1,513
Reserve & Surplus
405
409
513
696
876
978
1,078
1,313
1,472
Share Capital
10
10
10
10
10
10
10
10
42
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
4
14
-1
18
8
56
279
-321
3
-6
-23
Investing Activities
-56
96
-86
1
36
-104
63
-736
48
-89
-199
Operating Activities
70
91
102
104
90
215
249
253
247
264
263
Financing Activities
-10
-174
-17
-87
-118
-55
-33
163
-292
-181
-87
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
50.38 %
50.37 %
50.33 %
49.50 %
49.79 %
49.79 %
49.76 %
49.76 %
49.75 %
49.75 %
49.74 %
49.74 %
49.67 %
49.62 %
49.43 %
49.40 %
48.90 %
48.89 %
48.89 %
48.88 %
48.87 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
24.29 %
0.00 %
18.90 %
18.25 %
18.56 %
16.73 %
15.29 %
12.83 %
12.52 %
11.69 %
10.43 %
DIIs
15.34 %
14.22 %
11.77 %
10.63 %
15.32 %
13.85 %
11.88 %
13.30 %
13.64 %
14.47 %
16.86 %
20.28 %
24.86 %
27.43 %
28.02 %
30.00 %
30.30 %
32.40 %
33.10 %
34.73 %
35.79 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
3.95 %
3.98 %
4.24 %
6.50 %
9.14 %
9.26 %
9.45 %
9.73 %
8.53 %
8.15 %
7.78 %
6.63 %
5.24 %
4.07 %
3.54 %
3.34 %
3.84 %
4.16 %
3.69 %
3.87 %
3.99 %
Others
30.33 %
31.43 %
33.66 %
33.37 %
25.75 %
27.10 %
28.91 %
27.21 %
28.08 %
27.62 %
1.32 %
23.35 %
1.33 %
0.63 %
0.45 %
0.53 %
1.68 %
1.72 %
1.80 %
0.83 %
0.92 %
No of Share Holders
30,679
33,527
43,552
64,168
79,895
86,404
90,090
91,452
84,269
89,692
86,249
79,878
68,283
58,108
51,852
48,572
49,293
50,015
47,846
46,670
48,488

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 13.26 8 8 8 8 4 0.00 0.00
Dividend Yield (%) 0.00 0.00 4.13 1.43 1.57 2.56 1.86 1.02 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Feb 2021 DIVIDEND Dividend
₹ 8.00 /share
 17 Feb 2021 540.89 502.96
22 Feb 2022 DIVIDEND Dividend
₹ 8.00 /share
 21 Feb 2022 614.99 494.03
23 Feb 2023 DIVIDEND Dividend
₹ 8.00 /share
 23 Feb 2023 322.34 337.15
17 Nov 2023 DIVIDEND Dividend
₹ 4.00 /share
 17 Nov 2023 368.06 401.71
21 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 21 Aug 2024 524.58 522.89
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 08 Nov 2024 529.78 528.15
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Feb 2025 427.23 439.44
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 May 2025 423.70 428.08
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 07 Aug 2025 504.75 513.93
13 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 13 Aug 2025 484.70 523.23
04 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Nov 2025 488.30 501.11
11 Nov 2025 DIVIDEND Dividend
₹ 4.00 /share
 11 Nov 2025 501.11 484.01
04 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Feb 2026 450.80 476.08
20 Mar 2026 BONUS Bonus
3:1
 20 Mar 2026 454.70 456.29
13 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 13 May 2026 506.40 548.10
19 May 2026 DIVIDEND Dividend
₹ 1.00 /share
 19 May 2026 548.10 507.40

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 14, 2026
General UpdateMay 14, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 13, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 13, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMay 13, 2026
Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026May 13, 2026
Corporate Action-Board approves DividendMay 13, 2026
Board Meeting Outcome for The Meeting Held Today (May 13 2026)May 13, 2026
Grant Of Stock BenefitsMay 13, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMay 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 08, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 07, 2026
Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year Ended March 31 2026 And Declaration Of 2Nd Interim Dividend If Any For The Financial Year 2025-26May 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Business Update For Q4FY26Apr 03, 2026
Closure of Trading WindowMar 31, 2026
Announcement under Regulation 30 (LODR)-AllotmentMar 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2026
Intimation Of Record Date For The Purpose Of Issuing Bonus Equity SharesMar 10, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 09, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 02, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 04, 2026
Announcement under Regulation 30 (LODR)-RestructuringFeb 04, 2026
Corporate Action-Board recommends Bonus IssueFeb 04, 2026
Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 04, 2026
Board Meeting Outcome for The Meeting Held Today (February 04 2026)Feb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025 And Issuance Of Bonus SharesJan 30, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 13, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Business Update For Q3FY26Jan 05, 2026
Closure of Trading WindowDec 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 24, 2025
Intimation Of Cancellation Of Analyst / Institutional Investor Meeting Scheduled On November 21 2025Nov 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
The Wealth Company Small Cap Fund Direct-Growth
1.91%
16400
1.35%
1.91%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct-Growth
0.50%
-40
-0.03%
-0.03%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.03%
12
0.00%
0.00%
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth
0.52%
0
0.00%
-0.01%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
0.59%
0
0.00%
-0.01%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.42%
0
0.00%
0.06%
Aditya Birla Sun Life Regular Savings Fund Direct-Growth
0.44%
0
0.00%
0.00%
Aditya Birla Sun Life Regular Savings Fund Direct-Growth
0.44%
0
0.00%
0.00%
Aditya Birla Sun Life Retirement Fund - The 50s Plan Direct-Growth
1.08%
0
0.00%
0.07%
Angel One Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.36%
0
0.00%
0.01%
Bandhan Business Cycle Fund Direct-Growth
0.81%
0
0.00%
-0.01%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.13%
0
0.00%
-0.02%
Baroda BNP Paribas Children's Fund Direct-Growth
1.25%
0
0.00%
-0.01%
Baroda BNP Paribas Flexi Cap Fund Direct-Growth
1.41%
0
0.00%
-0.01%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
1.12%
0
0.07%
0.16%
Canara Robeco Small Cap Fund Direct-Growth
1.08%
0
0.00%
-0.05%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.26%
DSP Nifty Smallcap250 Quality 50 Index Fund Direct-Growth
1.12%
0
0.00%
-0.04%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Franklin India Aggressive Hybrid Fund Direct-Growth
1.16%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
65.88
ATR(14)
Volatile
22.38
STOCH(9,6)
Neutral
47.79
STOCH RSI(14)
Neutral
36.89
MACD(12,26)
Bullish
0.15
ADX(14)
Strong Trend
32.12
UO(9)
Bearish
58.11
ROC(12)
Uptrend And Accelerating
1.32
WillR(14)
Neutral
-42.81
Bearish
2
Neutral
4
Bullish
3

About Metropolis Healthcare

Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical...more
Listing Date
15 Apr, 2019(7 Years, 15 days)
Website
https://www.metropolisindia.com
Chairperson NameAmeera Sushil Shah
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104